Zerbaxa is an antibiotic used to treat adults and children with: • complicated (difficult to treat) infections of tissues and organs within the belly (intra-abdominal infections); • serious kidney infection (acute pyelonephritis); • complicated infections of the urinary tract (structures that carry urine, such as the bladder). It is also used to treat adults with hospital-acquired pneumonia (an infection of the lungs that is caught in the hospital), including ventilator-associated pneumonia (pneumonia in patients using a ventilator, a machine that helps a patient to breathe). Zerbaxa contains the active substances ceftolozane and tazobactam.
Therapeutic Indication
### Therapeutic indication Zerbaxa is indicated for the treatment of the following infections in adults: - Complicated intra abdominal infections; - Acute pyelonephritis; - Complicated urinary tract infections; - Hospital-acquired pneumonia (HAP), including ventilator associated pneumonia (VAP). Consideration should be given to official guidance on the appropriate use of antibacterial agents.
Therapeutic Area (MeSH)
N/AATC Code
J01DI54
ATC Item
ceftolozane and beta-lactamase inhibitor
Pharmacotherapeutic Group
Antibacterials for systemic use
Active Substance (Summary)
N/AINN / Common Names
N/AEMA Name
Zerbaxa
Medicine Name
Zerbaxa
Aliases
N/ANo risk management plan link.
